1
|
Mueller C, Nenert R, Catiul C, Pilkington J, Szaflarski JP, Amara AW. Relationship between sleep, physical fitness, brain microstructure, and cognition in healthy older adults: A pilot study. Brain Res 2024; 1839:149016. [PMID: 38768934 DOI: 10.1016/j.brainres.2024.149016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2024] [Revised: 05/01/2024] [Accepted: 05/17/2024] [Indexed: 05/22/2024]
Abstract
BACKGROUND There is a critical need for neuroimaging markers of brain integrity to monitor effects of modifiable lifestyle factors on brain health. This observational, cross-sectional study assessed relationships between brain microstructure and sleep, physical fitness, and cognition in healthy older adults. METHODS Twenty-three adults aged 60 and older underwent whole-brain multi-shell diffusion imaging, comprehensive cognitive testing, polysomnography, and exercise testing. Neurite Orientation Dispersion and Density Imaging (NODDI) was used to quantify neurite density (NDI) and orientation dispersion (ODI). Diffusion tensor imaging (DTI) was used to quantify axial diffusivity (AxD), fractional anisotropy (FA), mean diffusivity (MD), and radial diffusivity (RD). Relationships between sleep efficiency (SE), time and percent in N3 sleep, cognitive function, physical fitness (VO2 peak) and the diffusion metrics in regions of interest and the whole brain were evaluated. RESULTS Higher NDI in bilateral white and gray matter was associated with better executive functioning. NDI in the right anterior cingulate and adjacent white matter was positively associated with language skills. Higher NDI in the left posterior corona radiata was associated with faster processing speed. Physical fitness was positively associated with NDI in the left precentral gyrus and corticospinal tract. N3 % was positively associated with NDI in the left caudate and right pre- and postcentral gyri. Higher ODI in the left putamen and adjacent white matter was associated with better executive function. CONCLUSION NDI and ODI derived from NODDI are potential neuroimaging markers for associations between brain microstructure and modifiable risk factors in aging. If these associations are observable in clinical samples, NODDI could be incorporated into clinical trials assessing the effects of modifiable risk factors on brain integrity in aging and neurodegenerative diseases.
Collapse
Affiliation(s)
- Christina Mueller
- University of Alabama at Birmingham, Department of Neurology, 1719 6(th) Ave S, Birmingham, AL 35233, United States.
| | - Rodolphe Nenert
- University of Alabama at Birmingham, Department of Neurology, 1719 6(th) Ave S, Birmingham, AL 35233, United States
| | - Corina Catiul
- University of Alabama at Birmingham, Department of Neurology, 1719 6(th) Ave S, Birmingham, AL 35233, United States
| | - Jennifer Pilkington
- University of Alabama at Birmingham, Department of Neurology, 1719 6(th) Ave S, Birmingham, AL 35233, United States
| | - Jerzy P Szaflarski
- University of Alabama at Birmingham, Department of Neurology, 1719 6(th) Ave S, Birmingham, AL 35233, United States
| | - Amy W Amara
- University of Alabama at Birmingham, Department of Neurology, 1719 6(th) Ave S, Birmingham, AL 35233, United States; University of Colorado Anschutz Medical Campus, 1635 Aurora Ct, Aurora, CO 80045, United States
| |
Collapse
|
2
|
Koppula S, Wankhede NL, Sammeta SS, Shende PV, Pawar RS, Chimthanawala N, Umare MD, Taksande BG, Upaganlawar AB, Umekar MJ, Kopalli SR, Kale MB. Modulation of cholesterol metabolism with Phytoremedies in Alzheimer's disease: A comprehensive review. Ageing Res Rev 2024; 99:102389. [PMID: 38906182 DOI: 10.1016/j.arr.2024.102389] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2024] [Revised: 06/18/2024] [Accepted: 06/18/2024] [Indexed: 06/23/2024]
Abstract
Alzheimer's disease (AD) is a complex neurological ailment that causes cognitive decline and memory loss. Cholesterol metabolism dysregulation has emerged as a crucial element in AD pathogenesis, contributing to the formation of amyloid-beta (Aβ) plaques and tau tangles, the disease's hallmark neuropathological characteristics. Thus, targeting cholesterol metabolism has gained attention as a potential therapeutic method for Alzheimer's disease. Phytoremedies, which are generated from plants and herbs, have shown promise as an attainable therapeutic option for Alzheimer's disease. These remedies contain bioactive compounds like phytochemicals, flavonoids, and polyphenols, which have demonstrated potential in modulating cholesterol metabolism and related pathways. This comprehensive review explores the modulation of cholesterol metabolism by phytoremedies in AD. It delves into the role of cholesterol in brain function, highlighting disruptions observed in AD. Additionally, it examines the underlying molecular mechanisms of cholesterol-related pathology in AD. The review emphasizes the significance of phytoremedies as a potential therapeutic intervention for AD. It discusses the drawbacks of current treatments and the need for alternative strategies addressing cholesterol dysregulation and its consequences. Through an in-depth analysis of specific phytoremedies, the review presents compelling evidence of their potential benefits. Molecular mechanisms underlying phytoremedy effects on cholesterol metabolism are examined, including regulation of cholesterol-related pathways, interactions with Aβ pathology, influence on tau pathology, and anti-inflammatory effects. The review also highlights challenges and future perspectives, emphasizing standardization, clinical evidence, and personalized medicine approaches to maximize therapeutic potential in AD treatment. Overall, phytoremedies offer promise as a potential avenue for AD management, but further research and collaboration are necessary to fully explore their efficacy, safety, and mechanisms of action.
Collapse
Affiliation(s)
- Sushruta Koppula
- College of Biomedical and Health Sciences, Konkuk University, Chungju-Si, Chungcheongbuk Do 27478, Republic of Korea.
| | - Nitu L Wankhede
- Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra 441002, India.
| | - Shivkumar S Sammeta
- National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana 500037, India.
| | - Prajwali V Shende
- Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra 441002, India.
| | - Rupali S Pawar
- Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra 441002, India.
| | | | - Mohit D Umare
- Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra 441002, India.
| | - Brijesh G Taksande
- Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra 441002, India.
| | - Aman B Upaganlawar
- SNJB's Shriman Sureshdada Jain College of Pharmacy, Neminagar, Chandwad, Nashik, Maharashtra, India.
| | - Milind J Umekar
- Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra 441002, India.
| | - Spandana Rajendra Kopalli
- Department of Bioscience and Biotechnology, Sejong University, Gwangjin-gu, Seoul 05006, Republic of Korea.
| | - Mayur B Kale
- Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra 441002, India.
| |
Collapse
|
3
|
Delfan M, Kordestani-Moghaddam P, Gholami M, Kazemi K, Mohammadi R. Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial. Explore (NY) 2024; 20:102990. [PMID: 38538390 DOI: 10.1016/j.explore.2024.02.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2023] [Revised: 02/19/2024] [Accepted: 02/28/2024] [Indexed: 07/08/2024]
Abstract
INTRODUCTION Mild cognitive impairment is the middle level of natural cognitive impairment during primary steps of dementia. There are a few studies about improving the cognitive performance and sleep quality in patients with a limited dementia. So, this study was conducted to evaluate the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment. MATERIALS AND METHODS In this study, 62 patients with mild cognitive impairment were categorized into two groups of control and intervention. The intervention group received one pill of 160 mg Bacopa monnieri extract in 2 months, and the control group received a pill containing starch powder. The cognitive impairment and sleep quality was assessed using a questionnaire containing demographic information, Montreal Cognitive Assessment, and the Pittsburg Sleep Quality Index in three time-points of before the study, one months after the intervention and 2 months after the intervention (the end of study). RESULTS The results showed no statistically significant difference between two groups in all three time-points in overall cognitive performance score and its 6 parameters (P > 0.05). While in the field of attention at the end of the first month (P = 0.033) and the end of the second month (P = 0.004), it was significant difference between the study groups. Also, in the field of verbal fluency at the end of the second month, this difference was significant (P = 0.003). The cognitive performance overall score showed no significant difference between two groups in first (P = 0.939) and second time-points (P = 0.661), although it was significant at third time-point (P = 0.029). There was no statistically significant difference between two groups in all time-points for sleep quality overall score (P > 0.05). CONCLUSION The results showed that Bacopa monnieri can improve the cognitive performance overall score and some of its parameters, but it had no effect on sleep quality.
Collapse
Affiliation(s)
- Maryam Delfan
- Master of Medical-Surgical Nursing, Student Research Committee, Medical-Surgical Nursing Department, School of Nursing and Midwifery, Lorestan University of Medical Sciences, Khorramabad, Iran
| | - Parastou Kordestani-Moghaddam
- Assistant Professor of Cognitive Neuroscience, Social determinants of research health center, School of Nursing and midwifery, Emergency and Critical Care Nursing Depatrment, Lorestan University of Medical Sciences, Khorramabad, Iran.
| | - Mohammad Gholami
- Associate Professor, Social determinants of health reseachcenter, Medical Surgical Nursing Depatrment, School of Nursing and midwifery, Lorestan University of Medical Sciences, Khorramabad, Iran
| | - Khadije Kazemi
- MD, Neurologist, School of medicine, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khorramabad, Iran
| | - Rasool Mohammadi
- Assistant Professor of Epidemiology, Department of Biostatistics and Epidemiology, School of Public Health and Nutrition, Lorestan University of Medical Sciences, Khorramabad, Iran
| |
Collapse
|
4
|
Richter CG, Li CM, Turnbull A, Haft SL, Schneider D, Luo J, Lima DP, Lin FV, Davidson RJ, Hoeft F. Brain imaging studies of emotional well-being: a scoping review. Front Psychol 2024; 14:1328523. [PMID: 38250108 PMCID: PMC10799564 DOI: 10.3389/fpsyg.2023.1328523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2023] [Accepted: 12/06/2023] [Indexed: 01/23/2024] Open
Abstract
This scoping review provides an overview of previous empirical studies that used brain imaging techniques to investigate the neural correlates of emotional well-being (EWB). We compiled evidence on this topic into one accessible and usable document as a foundation for future research into the relationship between EWB and the brain. PRISMA 2020 guidelines were followed. We located relevant articles by searching five electronic databases with 95 studies meeting our inclusion criteria. We explored EWB measures, brain imaging modalities, research designs, populations studied, and approaches that are currently in use to characterize and understand EWB across the literature. Of the key concepts related to EWB, the vast majority of studies investigated positive affect and life satisfaction, followed by sense of meaning, goal pursuit, and quality of life. The majority of studies used functional MRI, followed by EEG and event-related potential-based EEG to study the neural basis of EWB (predominantly experienced affect, affective perception, reward, and emotion regulation). It is notable that positive affect and life satisfaction have been studied significantly more often than the other three aspects of EWB (i.e., sense of meaning, goal pursuit, and quality of life). Our findings suggest that future studies should investigate EWB in more diverse samples, especially in children, individuals with clinical disorders, and individuals from various geographic locations. Future directions and theoretical implications are discussed, including the need for more longitudinal studies with ecologically valid measures that incorporate multi-level approaches allowing researchers to better investigate and evaluate the relationships among behavioral, environmental, and neural factors. Systematic review registration https://osf.io/t9cf6/.
Collapse
Affiliation(s)
- Caroline G. Richter
- Department of Psychology, University of Alabama at Birmingham, Birmingham, AL, United States
- Department of Psychological Sciences, University of Connecticut, Storrs, CT, United States
| | - Celine Mylx Li
- Department of Psychological Sciences, University of Connecticut, Storrs, CT, United States
- Department of Psychology, University of California, Berkeley, Berkeley, CA, United States
| | - Adam Turnbull
- Department of Brain and Cognitive Sciences, University of Rochester, Rochester, NY, United States
- CogT Lab, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States
| | - Stephanie L. Haft
- Department of Psychology, University of California, Berkeley, Berkeley, CA, United States
| | - Deborah Schneider
- Department of Psychological Sciences, University of Connecticut, Storrs, CT, United States
| | - Jie Luo
- Department of Psychological Sciences, University of Connecticut, Storrs, CT, United States
| | - Denise Pinheiro Lima
- Intensive Care Pediatrician, Pediatric Intensive Care Unit, Hospital Moinhos de Vento, Porto Alegre, Brazil
| | - Feng Vankee Lin
- CogT Lab, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States
| | - Richard J. Davidson
- Center for Healthy Minds, University of Wisconsin, Madison, WI, United States
- Department of Psychology, University of Wisconsin, Madison, WI, United States
- Waisman Laboratory for Brain Imaging and Behavior, University of Wisconsin, Madison, WI, United States
- Department of Psychiatry, University of Wisconsin, Madison, WI, United States
| | - Fumiko Hoeft
- Department of Psychological Sciences, University of Connecticut, Storrs, CT, United States
- Haskins Laboratories, New Haven, CT, United States
- Brain Imaging Research Center (BIRC), University of Connecticut, Storrs, CT, United States
- Department of Psychiatry and Behavioral Sciences, and Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, United States
- Department of Neuropsychiatry, Keio University School of Medicine, Shinanomachi Shinjuku Tokyo, Tokyo, Japan
| |
Collapse
|
5
|
Srivastava P, Yadav D, Singh SK, Kim SH, Singh S, Katiyar S, Song M. Investigating Bacopa monnieri L. Therapeutic Potential for the Treatment of Neurological Diseases. Curr Pharm Des 2024; 30:1016-1030. [PMID: 38500283 DOI: 10.2174/0113816128288698240305094945] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2023] [Accepted: 02/16/2024] [Indexed: 03/20/2024]
Abstract
The popular perennial creeping plant known as Bacopa monnieri (also known as Brahmi) is being utilized in the Indian Ayurvedic medicine practice. It has a variety of bioactive phytoconstituents that have been used therapeutically to treat a number of serious illnesses. Ancient Vedic scholars used this herb because of its pharmacological effects, particularly as a nerve booster and nootropic supporter. However, it is vital to comprehend the active phytochemical components of Bacopa monnieri extract (BME) and their molecular mechanisms in order to better grasp the effect of BME on neurological illnesses and diseases. Understanding its active phytochemical constituents and their molecular processes is essential. Numerous clinical investigations indicated that BME may have neuroprotective benefits, so it is worthwhile to re-evaluate this wellknown plant. Here, we focused on neurological problems as we examined the pharmacological and phytochemical characteristics of BME. For their effective usage in neuroprotection and cognition, many clinical concerns and the synergistic potential of Bacopa extract have been investigated. Alzheimer's disease is a neurological condition caused by the production of reactive oxygen species, which also causes amyloid-beta (Aβ) and tau protein aggregation and increases neuro-inflammation and neurotoxicity. Our review offers a more indepth molecular understanding of the neuroprotective functions of BME, which can also be connected to its therapeutic management of neurological illnesses and cognitive-improving effects.
Collapse
Affiliation(s)
- Pratima Srivastava
- Department of Biotechnology, Arka Jain University, Seraikela Kharsawan, Jharkhand 832108, India
| | - Dhananjay Yadav
- Department of Life Science, Yeungnam University, Gyeongsan, Korea
| | - Santosh Kumar Singh
- Department of Biotechnology, Arka Jain University, Seraikela Kharsawan, Jharkhand 832108, India
| | - Sung Hae Kim
- Department of Pharmacology, College of Medicine, University of Ulsan, Ulsan, South Korea
| | - Shivendra Singh
- Department of Basic Sciences, Amity School of Engineering and Technology (ASET), Amity University, Indore, Madhya Pradesh, India
| | - Shweta Katiyar
- Department of Botany, SBN Government PG College, Barwani (M.P), India
| | - Minseok Song
- Department of Life Science, Yeungnam University, Gyeongsan, Korea
| |
Collapse
|
6
|
Malík M, Tlustoš P. Nootropic Herbs, Shrubs, and Trees as Potential Cognitive Enhancers. PLANTS (BASEL, SWITZERLAND) 2023; 12:plants12061364. [PMID: 36987052 PMCID: PMC10056569 DOI: 10.3390/plants12061364] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/24/2023] [Revised: 03/15/2023] [Accepted: 03/16/2023] [Indexed: 05/13/2023]
Abstract
Plant-based nootropics are a diverse group of natural drugs that can improve cognitive abilities through various physiological mechanisms, especially in cases where these functions are weakened or impaired. In many cases, the nootropics enhance erythrocyte plasticity and inhibit aggregation, which improves the blood's rheological properties and increases its flow to the brain. Many of these formulations possess antioxidant activity that protects brain tissue from neurotoxicity and improves the brain's oxygen supply. They can induce the synthesis of neuronal proteins, nucleic acids, and phospholipids for constructing and repairing neurohormonal membranes. These natural compounds can potentially be present in a great variety of herbs, shrubs, and even some trees and vines. The plant species reviewed here were selected based on the availability of verifiable experimental data and clinical trials investigating potential nootropic effects. Original research articles, relevant animal studies, meta-analyses, systematic reviews, and clinical trials were included in this review. Selected representatives of this heterogeneous group included Bacopa monnieri (L.) Wettst., Centella asiatica (L.) Urban, Eleutherococcus senticosus (Rupr. & Maxim.) Maxim., Ginkgo biloba L., Lepidium meyenii Walp., Panax ginseng C.A. Meyer, Paullinia cupana Kunth, Rhodiola rosea L., Schisandra chinensis (Turcz.) Baill., and Withania somnifera (L.) Dunal. The species are depicted and described, together with their active components and nootropic effects, and evidence of their efficacy is presented. The study provides brief descriptions of the representative species, their occurrence, history, and the chemical composition of the principle medicinal compounds, with uses, indications, experimental treatments, dosages, possible side effects, and contraindications. Most plant nootropics must be taken at optimal doses for extended periods before measurable improvement occurs, but they are generally very well tolerated. Their psychoactive properties are not produced by a single molecule but by a synergistic combination of several compounds. The available data suggest that including extracts from these plants in medicinal products to treat cognitive disorders can have substantial potential therapeutic benefits.
Collapse
|
7
|
Keegan AP, Stough C, Paris D, Luis CA, Abdullah L, Ait-ghezala G, Crawford F, Mullan M. Bacopa monnieri supplementation has no effect on serum brain-derived neurotrophic factor levels but beneficially modulates nuclear factor kappa B and cyclic AMP response element-binding protein levels in healthy elderly subjects. J Clin Transl Res 2023; 9:50-58. [PMID: 37032999 PMCID: PMC10075090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2022] [Revised: 11/23/2022] [Accepted: 11/23/2022] [Indexed: 04/11/2023] Open
Abstract
Background and Aim Bacopa monnieri is an Ayurvedic herb that has been used for multiple conditions, most notably to augment cognition, particularly memory and attention. Multiple mechanisms, including raising brain-derived neurotrophic factor (BDNF), have been proposed and investigated in animal models that require translational studies in humans. Methods Bacopa was administered in an open-labeled study to cognitively healthy controls over a 3-month period. Cognition and mood were assessed using the Montreal Cognitive Assessment (MoCA) and geriatric depression scale (GDS) at the baseline and 3-month visit. Laboratories were assessed for safety and serum levels of mature (mBDNF) and proBDNF were quantified. In a subset of subjects, intracellular signaling processes were assessed using western blot analysis. Results Bacopa was provided to 35 subjects and was well-tolerated except for 4 (11%) subjects who early terminated due to known, reversible, and gastrointestinal side effects (i.e., nausea, diarrhea). Over the 3 months, the GDS and the total MoCA did not significantly change; however, the delayed-recall subscale significantly improved (baseline: 3.8 ± 1.2, 3-months: 4.3 ± 0.9; P = 0.032). Serum mBDNF and proBDNF levels did not significantly change. Cyclic AMP response element-binding protein (CREB) phosphorylation significantly increased (P = 0.028) and p65 nuclear factor kappa B (NF-κB) phosphorylation significantly decreased (P = 0.030). Conclusion These results suggest that Bacopa may exert an anti-inflammatory effect through NF-κB and improve intracellular signaling processes associated with synaptogenesis (CREB). The future placebo-controlled studies are recommended. Relevance for Patients B. monnieri will require larger, blinded trials to better understand potential mechanisms, interactions, and utilization.
Collapse
Affiliation(s)
- Andrew P. Keegan
- The Roskamp Institute, Sarasota, Florida, United States of America
- Corresponding author: Andrew P. Keegan The Roskamp Institute, 2040 Whitfield Avenue, Sarasota, Florida 34243, United States of America. Tel: +1 941-752-2949. Fax: +1 941-752-2948.
| | - Con Stough
- Swinburne Centre for Human Psychopharmacology, Swinburne University, Melbourne, Australia
| | - Daniel Paris
- The Roskamp Institute, Sarasota, Florida, United States of America
| | - Cheryl A. Luis
- The Roskamp Institute, Sarasota, Florida, United States of America
| | - Laila Abdullah
- The Roskamp Institute, Sarasota, Florida, United States of America
| | | | - Fiona Crawford
- The Roskamp Institute, Sarasota, Florida, United States of America
| | - Michael Mullan
- The Roskamp Institute, Sarasota, Florida, United States of America
| |
Collapse
|